Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001453687-24-000117

Director acquired 1,518,373 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kalayoglu Murat Director 2024-10-11 Option exercise +1,518,373 4,555,260 I: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kalayoglu Murat Director 2024-10-11 Option exercise · Series A Non-Voting Convertible Preferred Stock −45,551.19 56,402.25 I: show line 2 in the form
Loading xslF345X05/wk-form4_1729025606.xml…